[Tickers Inside] 7 Solid Gainers Over the Last 5 Sessions

Stocks with 5 days of consecutive price advances. If you cannot see this email properly, please click [here]( --------------------------------------------------------------- Sponsor Message [Is Taiwan a Chinese Red Herring? The Real Threat to the U.S.]( [Click here for this rare investment opportunity]( --------------------------------------------------------------- March 03, 20223 From the desk of the Editor (5 Day Gainers Report) Dear Reader, We just identified 7 Five Day Gainers across all US Exchanges. If you are interested in any of these companies, we encourage you to do your own research and due diligence. Keep reading to see what we just uncovered... --------------------------------------------------------------- Sponsor Message [China Threat Triggers Potential Mining Boom for Investors]( has almost a 90% lock on critical minerals needed to produce our military, mobile, and green technologies. Mining companies are scrambling to find domestic sources to break China's chokehold on supply chains. Nevada, Idaho and Montana are key to securing a domestic supply. [Discover the one company set to break China's grip on critical minerals]( --------------------------------------------------------------- [MoonLake Immunotherapeutics, MLTX]( Recent Analyst Action: Prakhar Agrawal, analyst at Cantor Fitzgerald, reiterates coverage on [MoonLake Immunotherapeutics (MLTX)](in the Healthcare sector with a Buy rating and a price target of $23.00 (2 weeks ago). - Recent Price: $$22.224 - Average Analyst Price Target: $24.50 (10.24%) - Market Cap: $$1.18B [TipRanks.com]( also reports that [MoonLake Immunotherapeutics](currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $24.50 . The target pricing ranges from a high forecast of $28.00 down to a low forecast of $22.00. [MoonLake Immunotherapeutics (MLTX)](’s last closing price was $$22.224 which would put the average price target at $$24.50. Here are 3rd party ratings for [MLTX](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Top 40% (100 out of 250) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [The Dividend Stock to Leave for Your Grandchildren]( you tired of your so-called "safe" income stocks slashing dividends while the share prices fall? There is a better way. I just revealed my safest most reliable and [most consistent dividend stock]( - and it pays a sky high yield with dividends paid EVERY month. This company has also increased its monthly dividend twice a year every year for the past 8 years. [Tap here to reveal the name of this stock for free.]( --------------------------------------------------------------- [Pennant Group, PNTG]( Recent Analyst Action: Ryan MacDonald, analyst at Needham, reiterates coverage on [Pennant Group (PNTG)](in the Healthcare sector with a Hold rating and a price target of $15.00 (4 days ago). - Recent Price: $$15.32 - Average Analyst Price Target: $16.33 (6.59%) - Market Cap: $$447.66M [TipRanks.com]( also reports that [Pennant Group](currently has 3 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $16.33 . The target pricing ranges from a high forecast of $18.00 down to a low forecast of $15.00. [Pennant Group (PNTG)](’s last closing price was $$15.32 which would put the average price target at $$16.33. Here are 3rd party ratings for [PNTG](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: buy - Zacks.com: Buy, Bottom 38% (154 out of 250) [Click here for chart >>]( -------------------------------------------------------------------------- [Checkpoint Therapeutics, CKPT]( Recent Analyst Action: Mayank Mamtani, analyst at B.Riley Financial, reiterates coverage on [Checkpoint Therapeutics (CKPT)](in the Healthcare sector with a Buy rating and a price target of $15.00 (1 day ago). - Recent Price: $$5.19 - Average Analyst Price Target: $35.33 (580.73%) - Market Cap: $$78.95M [TipRanks.com]( also reports that [Checkpoint Therapeutics](currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $35.33 . The target pricing ranges from a high forecast of $76.00 down to a low forecast of $15.00. [Checkpoint Therapeutics (CKPT)](’s last closing price was $$5.19 which would put the average price target at $$35.33. Here are 3rd party ratings for [CKPT](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong sell - Zacks.com: n/a, n/a [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [Disturbing Truth About Biden's New Program To Seize Your Cash]( s disturbing new government program may be worse than Obama's. You are at risk for having your bank account frozen. A former bank regulator is blowing the whistle on Biden's frightening plan to take over your money. Discover the immediate steps you need to take now. [Get The Rest Of The Details Here]( --------------------------------------------------------------- [Playa Hotels & Resorts, PLYA]( Recent Analyst Action: Tyler Batory, analyst at Oppenheimer, reiterates coverage on [Playa Hotels & Resorts (PLYA)](in the Services sector with a Buy rating and a price target of $14.00 (3 days ago). - Recent Price: $$9.545 - Average Analyst Price Target: $12.67 (32.74%) - Market Cap: $$1.53B [TipRanks.com]( also reports that [Playa Hotels & Resorts](currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $12.67 . The target pricing ranges from a high forecast of $15.00 down to a low forecast of $9.00. [Playa Hotels & Resorts (PLYA)](’s last closing price was $$9.545 which would put the average price target at $$12.67. Here are 3rd party ratings for [PLYA](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Strong Buy, Top 14% (34 out of 250) [Click here for chart >>]( -------------------------------------------------------------------------- [Diamond Offshore Drilling Inc, DO]( Recent Analyst Action: David Anderson, analyst at Barclays, reiterates coverage on [Diamond Offshore Drilling Inc (DO)](in the Industrial Goods sector with a Buy rating and a price target of $20.00 (10 hours ago). - Recent Price: $$12.51 - Average Analyst Price Target: $20.00 (59.87%) - Market Cap: $$1.27B [TipRanks.com]( also reports that [Diamond Offshore Drilling Inc](currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $20.00 . The target pricing ranges from a high forecast of $20.00 down to a low forecast of $20.00. [Diamond Offshore Drilling Inc (DO)](’s last closing price was $$12.51 which would put the average price target at $$20.00. Here are 3rd party ratings for [DO](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: n/a, n/a [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [This Plan Could Devastate Your Retirement Savings]( Wall Street insider goes public with the true story of the most harmful action against the wealth of the American people. [See the proof here.]( --------------------------------------------------------------- [Noble Corporation PLC Class A, NE]( Recent Analyst Action: David Anderson, analyst at Barclays, reiterates coverage on [Noble Corporation PLC Class A (NE)](in the Industrial Goods sector with a Buy rating and a price target of $56.00 (10 hours ago). - Recent Price: $$44.16 - Average Analyst Price Target: $53.00 (20.02%) - Market Cap: $$5.95B [TipRanks.com]( also reports that [Noble Corporation PLC Class A](currently has 3 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $53.00 . The target pricing ranges from a high forecast of $56.00 down to a low forecast of $50.00. [Noble Corporation PLC Class A (NE)](’s last closing price was $$44.16 which would put the average price target at $$53.00. Here are 3rd party ratings for [NE](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: n/a, n/a [Click here for chart >>]( -------------------------------------------------------------------------- [Heritage Insurance Holdings, HRTG]( Recent Analyst Action: Nicole Miller, analyst at Piper Sandler, reiterates coverage on [Heritage Insurance Holdings (HRTG)](in the Financial sector with a Hold rating and a price target of $2.20 (2 weeks ago). - Recent Price: $$3.31 - Average Analyst Price Target: $2.60 (-21.45%) - Market Cap: $$70.38M [TipRanks.com]( also reports that [Heritage Insurance Holdings](currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $2.60 . The target pricing ranges from a high forecast of $3.00 down to a low forecast of $2.20. [Heritage Insurance Holdings (HRTG)](’s last closing price was $$3.31 which would put the average price target at $$2.60. Here are 3rd party ratings for [HRTG](: - TipRanks.com: Moderate Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: buy - Zacks.com: Hold, Top 43% (107 out of 250) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Sponsor Message [China Threatens U.S. Defense and Economic Security]( doesn't need to fire a single shot to dominate America. Instead, it can ban exports of critical minerals the U.S. needs for high-tech military weapons and green and mobile technologies. China controls up to 90% of these markets. It's a National Emergency and an opportunity for investors to jump on the next boom of mining companies exploring in the U.S. [Click here for details.]( --------------------------------------------------------------- And there you have it--7 Five Day Gainers across all US Exchanges. Sincerely, Editor, MarketTickerPress.com Market Ticker Press Disclaimer This newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this newsletter or email is not provided to any individual with a view toward their individual circumstances. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this newsletter as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. By opening and/or clicking a link containted within this email, you are reconfirming your opt-in status. You can unsubscribe at any time. MarketTickerPress.com part of Sandpiper Marketing Group | 1519 Mecklenburg Hwy | Unit 4 | Mt. Mourne | North Carolina | 28123 | United States | 877-411-9808 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software